ZLMT-72
ZLMT-72 is an orally active dual CDK2 and CDK9 inhibitor with IC50s of 0.741 nM and 1.03 nM, respectively. ZLMT-72 shows good selectivity in kinase profiling andcholinesterase inhibition activity. ZLMT-72 has strong antiproliferative effects in the colorectal cancer (CRC) cell line HCT116 (GI50 < 0.1 nM). ZLMT-72 induces apoptosis by inhibiting thephosphorylation of retinoblastoma and RNA polymerase II, resulting in downregulation of antiapoptotic proteins (Mcl-1 and XIAP). ZLMT-72 can be used for the study of colorectal cancer (CRC).
For research use only. We do not sell to patients.
- Formula: C29H32FN5O
- Molecular Weight:485.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
RNA Polymerase |
CDK2/CycA2 0.741 (IC50) |
CDK9/CycT1 1.03 (IC50) |
Mcl-1 |
XIAP |
In Vitro
ZLMT-72 (1-10 nM; 10 days) completely suppresses colony formation in HCT116 cells[1].
ZLMT-72 (1-10 nM; 72 hours) demonstrates potent antiproliferative effects in HCT116 cells[1].
ZLMT-72 (1-10 nM; 48 hours) induces significant apoptosis in HCT116 cells[1].
ZLMT-72 (1-10 nM; 24 hours) significantly inhibits HCT116 cell migration[1].
ZLMT-72 (1-10 nM; 48 hours) inhibits CDK2/9 and reduces antiapoptotic protein expression in HCT116 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT116 cells
-
Concentration:1 nM, 3.3 nM, 10 nM
-
Incubation Time:72 hours
-
Result:Exhibited potent antiproliferative effects, with GI50 values < 0.1 nM. The compound significantly inhibited cell proliferation.
-
Cell Line:HCT116 cells
-
Concentration:1 nM, 3.3 nM, 10 nM
-
Incubation Time:10 days
-
Result:Completely suppressed colony formation in HCT116 cells at 10 nM, demonstrating strong antiproliferative activity.
-
Cell Line:HCT116 cells
-
Concentration:10 nM, 3.3 nM, 1 nM
-
Incubation Time:48 hours
-
Result:Induced apoptosis in 30.19% of HCT116 cells at 10 nM, with 23.3% early-stage and 6.89% late-stage apoptosis.
-
Cell Line:HCT116 cells
-
Concentration:1 nM, 3.3 nM, 10 nM
-
Incubation Time:24 hours
-
Result:Significantly inhibited HCT116 cell migration at 10 nM and 3.3 nM, with a reduced migration rate.
-
Cell Line:HCT116 cells
-
Concentration:10 nM, 3.3 nM, 1 nM
-
Incubation Time:48 hours
-
Result:Significantly downregulated the levels of phosphorylated Rb (p-Rb) and inhibited the phosphorylation of RNA polymerase II at the Ser2 site, indicating CDK2/9 inhibition.
Also reduced the expression of antiapoptotic proteins (MCL-1 and XIAP).
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c nude mice bearing HCT116 cells (subcutaneous and orthotopic xenograft tumor models)[1]
-
Dosage:10 mg/kg, 3.3 mg/kg, 1.1 mg/kg
-
Administration:Oral, oral, twice daily, for 14 days
-
Result:Tumor growth was significantly inhibited in both subcutaneous and orthotopic models.
At 10 mg/kg, tumor growth inhibition (TGI) was 50.6% in subcutaneous models and 84.3% in orthotopic models.
Revealed a significantred reduction in Ki67-positive and CDK20-positive cells.
Tumor weight and volume were significantly reduced, and no significant toxicity was observed.
Chemical Information
-
Molecular Weight 485.60
-
Formula C29H32FN5O
-
SMILES
O=C([C@@H]1[C@@H](F)C1)NC2=CC(C3=CC=C(N=C(CCCCC4)C4=C5N6C[C@@H](CNC7)[C@@H]7C6)C5=C3)=CC=N2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)